Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Prediction of therapy tumor-absorbed dose estimates in I-131 radioimmunotherapy using tracer data via a mixed-model fit to time activity.

Schipper MJ, Koral KF, Avram AM, Kaminski MS, Dewaraja YK.

Cancer Biother Radiopharm. 2012 Sep;27(7):403-11. doi: 10.1089/cbr.2011.1053.

2.
3.

Radioimmunotherapy dosimetry--a review.

Strand SE, Jönsson BA, Ljungberg M, Tennvall J.

Acta Oncol. 1993;32(7-8):807-17. Review.

PMID:
8305230
4.

Tumor dosimetry in radioimmunotherapy: methods of calculation for beta particles.

Leichner PK, Kwok CS.

Med Phys. 1993 Mar-Apr;20(2 Pt 2):529-34. Review.

PMID:
8492761
5.

Dosimetry in patients with B-cell lymphoma treated with [(90)Y]ibritumomab tiuxetan or [(131)I]tositumomab.

Sjögreen-Gleisner K, Dewaraja YK, Chiesa C, Tennvall J, Lindén O, Strand SE, Ljungberg M.

Q J Nucl Med Mol Imaging. 2011 Apr;55(2):126-54. Review.

PMID:
21386787
6.

Radio-immunotherapy dosimetry with special emphasis on SPECT quantification and extracorporeal immuno-adsorption.

Strand SE, Ljungberg M, Tennvall J, Norrgren K, Garkavij M.

Med Biol Eng Comput. 1994 Sep;32(5):551-61. Review.

PMID:
7845072
7.

Radiolabeled and native antibodies and the prospect of cure of follicular lymphoma.

Buchegger F, Press OW, Delaloye AB, Ketterer N.

Oncologist. 2008 Jun;13(6):657-67. doi: 10.1634/theoncologist.2008-0020. Review.

8.

A systematic literature review and meta-analysis of radioimmunotherapy consolidation for patients with untreated follicular lymphoma.

Rose AC, Shenoy PJ, Garrett G, Seward M, Kucuk RA, Doksansky H, Nastoupil LJ, Flowers CR.

Clin Lymphoma Myeloma Leuk. 2012 Dec;12(6):393-9. doi: 10.1016/j.clml.2012.09.012. Review.

PMID:
23158095
9.

The role of nuclear medicine in the treatment of non-Hodgkin's lymphoma (NHL).

Bischof Delaloye A.

Leuk Lymphoma. 2003;44 Suppl 4:S29-36. Review.

PMID:
15154740

Supplemental Content

Support Center